The Effectiveness of Co-packaging With Zinc to Improve Treatment of Diarrhea and Pneumonia in Guatemala
Zinc10
Measuring the Effectiveness of Co-packaging to Improve Provider and Caregiver Behavior in the Treatment of Diarrhea With Zinc & ORS and Pneumonia With Zinc & Antibiotics for Children Under 5 Yrs From San Marcos, Guatemala
1 other identifier
interventional
320
1 country
1
Brief Summary
This project applies a randomized community design to test the effectiveness of health center level co-packaging and counseling messages to improve provider and caregiver behavior in the treatment of diarrhea with zinc \& oral rehydration salts (ORS) and treatment of pneumonia with zinc \& antibiotics in children aged 2-59 mo old. We will evaluate the adherence of caregivers in 10 health posts in 5 municipalities randomly assigned to receive the health center level co-packaging and counseling messages in addition to current standard care, by comparing them with the caregivers in 10 health posts in 5 municipalities randomly assigned to the receive only the current standard of care. Cost-effectiveness of co-packaging at the health-center level, as a means of improving provider treatment and counseling practices and caregiver adherence, will be evaluated. The main objective is to establish the effectiveness of a facility level co-packaging and counseling messages for increasing the adherence by caregivers of children aged 2-59 mo old to the prescribed 10 day treatment with zinc to complement ORS for the treatment of diarrhea and zinc to complement the antibiotics for the treatment of pneumonia diagnosed and treated in public health posts. Specific Quantitative Objectives:
- To determine if visible co-packaging with pre-tested counseling messages:
- Improves adherence of caregivers of children towards the prescribed zinc treatment.
- Improves knowledge, awareness or attitudes of caregivers of children and health providers at public health care centers towards the prescribed zinc treatment.
- Results in overall increase in health care-seeking for the treatment of diarrhea and pneumonia at public health care centers. Specific Qualitative Objectives:
- To establish the perception, attitudes and experiences of caregivers towards the visible co-packaging with pre-tested counseling messages to promote the prescribed zinc treatment.
- To establish the perception, attitudes and experiences of health providers at public health care centers towards the visible co-packaging with pre-tested counseling messages to promote the prescribed zinc treatment.
- To establish the perception, attitudes and experiences of children aged 4 to 5 years old towards the visible co-packaging with pre-tested counseling messages to promote the prescribed zinc treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2014
CompletedFirst Posted
Study publicly available on registry
January 23, 2014
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedJanuary 24, 2014
January 1, 2014
3 months
January 21, 2014
January 23, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percentage of caregivers who administer zinc to child for at least 8 days.
Improved adherence to diarrhea or pneumonia treatment with zinc for the prescribed 10 days based on pill count in the home. Expressed as percentage of caregivers who administer zinc to child for at least 8 days.
10 days
Percentage of caregivers who report giving zinc to child for at least 8 days.
Improved adherence to diarrhea or pneumonia treatment with zinc for the prescribed 10 days based on self-reports. Expressed as percentage of caregivers who report administering zinc to child for at least 8 days.
10 days
Secondary Outcomes (1)
Improved Provision of Care for Treatment of Diarrhea and Pneumonia
6 months
Study Arms (2)
Co-packaging and counseling messages
EXPERIMENTALCurrent standard care at public health center ( zinc ORS for treatment of diarrhea and antibiotics for treatment of of pneumonia). The intervention consists of health center level co-packaging and visual counseling messages (zinc \& ORS packaged at health center for diarrhea, and zinc \& antibiotics co-packaged at health center for pneumonia) Co-packaging is done in a plastic bag, which is covered with pre-tested zinc treatment messages - a distinct packaging has been designed for diarrhea and for pneumonia
Control group
NO INTERVENTIONCurrent standard care at public health center (zinc \& ORS for treatment of diarrhea and zinc \& antibiotics for treatment of of pneumonia).
Interventions
The intervention involves co-packaging in 2 distinct packages: 1) for diarrhea treatment to package zinc \& ORS for the treatment of diarrhea using a plastic bag with printed messages that were pre-tested in formative research; and 2) for pneumonia treatment to co-package zinc \& antibiotics in a plastic bag with printed messages that were pre-tested in a formative research phase. Pre-tested zinc treatment messages will be on posters displayed in the intervention health centers. Orientation will be provided to health facility staff in control and intervention areas.
Eligibility Criteria
You may qualify if:
- The child is aged between between 2 and 59 mo old (\< 5 years old).
- The child is diagnosed with diarrhea or pneumonia at one of the selected public health care centers.
- The caregiver accompanying the child to the public health care centers must live in the same household.
You may not qualify if:
- Unwillingness to sign consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guatemala: Ministry of Public Health and Social Assistance
San Marcos, Departamento de San Marcos, 012001, Guatemala
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Marion Roche, PhD
Micronutrient Initiative
- PRINCIPAL INVESTIGATOR
María del Rosario García Meza, MA
Center for Studies of Sensory Impairment, Aging and Metabolism
- STUDY CHAIR
Noel W Solomons, MD
Center for Studies of Sensory Impairment, Aging and Metabolism
- PRINCIPAL INVESTIGATOR
Marieke Vossenaar, PhD
Center for Studies of Sensory Impairment, Aging and Metabolism
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Program Leader for Diet and Health
Study Record Dates
First Submitted
January 21, 2014
First Posted
January 23, 2014
Study Start
February 1, 2014
Primary Completion
May 1, 2014
Study Completion
June 1, 2014
Last Updated
January 24, 2014
Record last verified: 2014-01